Can a smart patch predict dangerous immune reactions in cancer treatment?
NCT ID NCT07499128
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a wearable patch called TempTraq can detect fevers earlier than standard temperature checks in cancer patients receiving immunotherapy. The goal is to see if continuous monitoring reduces the risk of severe cytokine release syndrome (CRS), a serious side effect. About 136 adults with cancer will wear the patch for up to 15 days while in the hospital. Some may also use a smartphone app to measure vital signs. The study is observational and does not provide a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TempTraq wearable patch and VitalTraq app
- What this could lead to
- If successful, this could lead to earlier detection of fevers from cytokine release syndrome, potentially reducing severe complications in cancer patients receiving immunotherapy.
- What could go wrong
- This is an early-stage observational study with only 136 participants, so results may not apply to all patients. The patch monitors temperature but does not prevent CRS, and its benefit over standard care is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBODIES BISPECIFIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a radioactive tracer reveal whether immunotherapy is working?
- Can a targeted pill slow brain tumor growth after surgery?
- A virtual Walk-Through of radiotherapy may calm cancer Patients' nerves
- Money worries and cancer: can talking about both ease the burden?
- Digital navigator aims to cut financial toxicity for young adults with cancer